| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 27.27B | 28.00B | 27.35B | 26.31B | 26.13B | 23.87B |
| Gross Profit | 7.27B | 7.60B | 6.87B | 5.75B | 5.17B | 5.13B |
| EBITDA | 3.52B | 3.97B | 3.33B | 2.52B | 2.31B | 2.30B |
| Net Income | 1.35B | 1.99B | 1.19B | 182.15M | 760.68M | 946.79M |
Balance Sheet | ||||||
| Total Assets | 38.34B | 41.63B | 38.34B | 36.48B | 38.12B | 32.14B |
| Cash, Cash Equivalents and Short-Term Investments | 7.02B | 9.19B | 5.93B | 4.53B | 9.35B | 4.05B |
| Total Debt | 8.80B | 9.00B | 8.81B | 8.12B | 6.80B | 2.30B |
| Total Liabilities | 14.71B | 15.84B | 14.60B | 13.71B | 12.38B | 7.18B |
| Stockholders Equity | 23.26B | 25.38B | 23.38B | 22.29B | 25.32B | 24.58B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.24B | 1.25B | -1.81B | 1.66B | -1.57B |
| Operating Cash Flow | 0.00 | 5.17B | 3.56B | -271.66M | 2.47B | 196.10M |
| Investing Cash Flow | 0.00 | -1.75B | -2.57B | -2.09B | -1.42B | -2.04B |
| Financing Cash Flow | 0.00 | -344.05M | 305.30M | -2.55B | 4.18B | 163.73M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥271.15B | 13.32 | ― | 1.53% | 9.71% | 54.82% | |
75 Outperform | ¥12.02B | 11.32 | ― | 3.02% | 3.53% | -0.12% | |
74 Outperform | ¥128.74B | 7.89 | 8.07% | 2.64% | 81.06% | 65.92% | |
72 Outperform | ¥30.88B | 10.88 | ― | 2.35% | 2.37% | 66.64% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
59 Neutral | ¥56.10B | -60.12 | ― | 5.01% | -25.54% | -166.77% | |
58 Neutral | ¥44.36B | 11.47 | ― | 0.91% | 11.44% | -4.29% |